BLUEPRINT MEDICINES CORP (BPMC) Institutional Ownership
None of the superinvestors we track currently report BLUEPRINT MEDICINES CORP (BPMC) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in BLUEPRINT MEDICINES CORP (BPMC), this page will show asset manager ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q2 2025 | 2 | $88,587,121 | 691,115 |
| Q1 2025 | 1 | $1,476,258 | 16,679 |
| Q4 2024 | 2 | $12,454,929 | 142,799 |
| Q3 2024 | 2 | $17,650,203 | 190,813 |
| Q2 2024 | 2 | $13,649,475 | 126,642 |
| Q1 2024 | 2 | $1,846,687 | 56,178 |
| Q4 2023 | 1 | $1,774,236 | 19,235 |
| Q3 2023 | 1 | $1,245,004 | 24,791 |
| Q2 2023 | 1 | $1,500,368 | 23,740 |
| Q1 2023 | 1 | $1,061,899 | 23,603 |
| Q4 2022 | 2 | $1,030,472 | 108,836 |
| Q3 2022 | 1 | $1,152 | 17,487 |
Related BPMC Institutional Insights:
- BPMC Institutional Ownership & Insiders Activity
- BPMC Institutional Ownership & 13F Activity
- BPMC Top Institutional Shareholders
- BPMC Institutional Buying Activity
- BPMC Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- BPMC Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings